Lin Mei
Impact in
- Biomaterials top 0.05%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.05%
- Nanoplatforms for cancer theranostics
- Bone Tissue Engineering Materials
Papers in
- Biomaterials 67
- Nanoparticle-Based Drug Delivery 66
-
- Nanoplatforms for cancer theranostics 74
- Co-authors
- Xiaowei Zeng (90 shared papers)Wei Tao (35 shared papers)Si‐Shen Feng (17 shared papers)Laiqiang Huang (40 shared papers)Xiaoyuan Ji (26 shared papers)Xudong Zhang (31 shared papers)Zimu Li (19 shared papers)Hongzhong Chen (22 shared papers)
- Journals
- Journal of Controlled Release (15 papers)Advanced Functional Materials (14 papers)Biomaterials (12 papers)Acta Biomaterialia (11 papers)Acta Pharmaceutica Sinica B (9 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Lin Mei
275 papers receiving 21.6k citations
Lin Mei's Hit Papers
Peers
Comparison fields: 5 of 123
- Biomaterials 4.8k
- Biomedical Engineering 5.1k
- Drug Discovery 9
- Pharmaceutical Science 754
- Molecular Medicine 335
Countries citing papers authored by Lin Mei
This map shows the geographic impact of Lin Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Mei more than expected).
Fields of papers citing papers by Lin Mei
This network shows the impact of papers produced by Lin Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Mei. The network helps show where Lin Mei may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Mei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 285 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Versatile Polydopamine Platforms: Synthesis and Promising Applications for Surface Modification and Advanced Nanomedicine Hit paper breakdown → | 2019 | 959 |
| 2 | 2005 | 862 | |
| 3 | Black Phosphorus Nanosheets as a Robust Delivery Platform for Cancer Theranostics Hit paper breakdown → | 2016 | 842 |
| 4 | Recent progress in drug delivery Hit paper breakdown → | 2019 | 686 |
| 5 | Polydopamine‐Modified Black Phosphorous Nanocapsule with Enhanced Stability and Photothermal Performance for Tumor Multimodal Treatments Hit paper breakdown → | 2018 | 560 |
| 6 | 2D Black Phosphorus–Based Biomedical Applications Hit paper breakdown → | 2019 | 541 |
| 7 | 2014 | 519 | |
| 8 | 2017 | 423 | |
| 9 | A Novel Top‐Down Synthesis of Ultrathin 2D Boron Nanosheets for Multimodal Imaging‐Guided Cancer Therapy Hit paper breakdown → | 2018 | 422 |
| 10 | Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation Hit paper breakdown → | 2019 | 369 |
| 11 | 2012 | 337 | |
| 12 | 2017 | 295 | |
| 13 | 2017 | 292 | |
| 14 | 2019 | 287 | |
| 15 | 2009 | 285 | |
| 16 | 2013 | 282 | |
| 17 | 2013 | 280 | |
| 18 | 2013 | 260 | |
| 19 | 2017 | 260 | |
| 20 | 2015 | 256 |
About Lin Mei
Lin Mei is a scholar working on Biomaterials, Biomedical Engineering, Pharmaceutical Science, Immunology and Molecular Biology, having authored 285 papers that have together received 22.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (74 papers), Nanoparticle-Based Drug Delivery (66 papers), RNA Interference and Gene Delivery (10 papers), Immunotherapy and Immune Responses (7 papers), Advancements in Transdermal Drug Delivery (6 papers), Osteoarthritis Treatment and Mechanisms (3 papers), Wound Healing and Treatments (3 papers) and Cardiac Fibrosis and Remodeling (3 papers). The work is most often cited by research in Biomaterials (4.8k citations), Biomedical Engineering (5.1k citations), Drug Discovery (9 citations), Pharmaceutical Science (754 citations) and Molecular Medicine (335 citations). Lin Mei has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Xiaowei Zeng, Wei Tao, Si‐Shen Feng, Laiqiang Huang, Xiaoyuan Ji, Xudong Zhang, Zimu Li, Hongzhong Chen, Gan Liu and Han Zhang. Their work appears in journals such as Journal of Controlled Release, Advanced Functional Materials, Biomaterials, Acta Biomaterialia and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.